immune system
• enhanced IL-33 responsiveness in IL5/IL13-producing pathogenic Th2 cells
• increased intracellular reactive oxygen species after stimulation with PMA/ionomycin or TCR stimulation
|
• mice sensitized with ovalbumin/alum-sensitized and restimulated exhibit increased IL5, IL13, eosinophil infiltration, and mucus production in the lungs compared with wild-type mice
|
• following injection of external, harmful Alternaria extract, mice exhibit increased IL33 and lactate dehydrogenase secretion into alveolar spaces compared with wild-type mice
• after the third ovalbumin aerosol challenge, mice exhibit increased IL33 secretion into the alveolar spaces compared with wild-type mice
• however, IL33 secretion from bone marrow cells is normal
|
• in lung homogenate of ovalbumin/alum-sensitized mice restimulated with ovalbumin
|
• from spleen cells and thoracic lymph nodes isolated from ovalbumin/alum-sensitized mice restimulated with ovalbumin
• in lung homogenate of ovalbumin/alum-sensitized mice restimulated with ovalbumin
|
respiratory system
• in mice sensitized with ovalbumin/alum-sensitized and restimulated
|
homeostasis/metabolism
• following injection of external, harmful Alternaria extract, mice exhibit increased IL33 and lactate dehydrogenase secretion into alveolar spaces compared with wild-type mice
|
cellular
• increased intracellular reactive oxygen species after stimulation with PMA/ionomycin or TCR stimulation
|
hematopoietic system
• enhanced IL-33 responsiveness in IL5/IL13-producing pathogenic Th2 cells
• increased intracellular reactive oxygen species after stimulation with PMA/ionomycin or TCR stimulation
|